P

Inventor

WANG ANLAI

US36 patents
⚠️ This page may combine multiple inventors who share the name “WANG ANLAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

32 patents
US10934288B2Mar 2, 2021

Pyrazolopyridine compounds and uses thereof

INCYTE CORP13 citations94
US10435405B2Oct 8, 2019

Pyrazolopyridine compounds and uses thereof

INCYTE CORP23 citations94
US10266530B2Apr 23, 2019

Pyrazolopyridine compounds and uses thereof

INCYTE CORP24 citations94
US9278950B2Mar 8, 2016

Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors

INCYTE CORP24 citations94
US9676750B2Jun 13, 2017

Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors

INCYTE CORP18 citations93
US9540347B2Jan 10, 2017

Pyridineamine compounds useful as Pim kinase inhibitors

INCYTE CORP19 citations93
US9580418B2Feb 28, 2017

Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors

INCYTE CORP19 citations92
US9556197B2Jan 31, 2017

Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors

INCYTE CORP19 citations92
US11492354B2Nov 8, 2022

Indazole compounds and uses thereof

INCYTE CORP8 citations86
US10752635B2Aug 25, 2020

Indazole compounds and uses thereof

INCYTE CORP16 citations86
US11607416B2Mar 21, 2023

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP7 citations85
US10450296B2Oct 22, 2019

Heterocyclic compounds useful as Pim kinase inhibitors

INCYTE CORP6 citations84
US10000507B2Jun 19, 2018

Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors

INCYTE CORP12 citations84
US9920032B2Mar 20, 2018

Heterocyclic compounds useful as pim kinase inhibitors

INCYTE CORP12 citations84
US7511050B2Mar 31, 2009

Purinone derivatives as HM74A agonists

INCYTE CORP14 citations84
US7576089B2Aug 18, 2009

3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors

INCYTE CORP8 citations83
US12384778B2Aug 12, 2025

Pyrazolopyridine compounds and uses thereof

INCYTE CORP1 citations75
US7678798B2Mar 16, 2010

Piperazinylpiperidine derivatives as chemokine receptor antagonists

INCYTE CORP5 citations74
US7462624B2Dec 9, 2008

Purinone derivatives as HM74a agonists

INCYTE CORP8 citations74
US11795166B2Oct 24, 2023

Pyrazolopyridine compounds and uses thereof

INCYTE CORP2 citations73
US11229631B2Jan 25, 2022

Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors

INCYTE CORP0 citations63
US11053215B2Jul 6, 2021

Heterocyclic compounds useful as Pim kinase inhibitors

INCYTE CORP1 citations63
US7902205B2Mar 8, 2011

Purinone derivatives as HM74A agonists

INCYTE CORP3 citations63
US12441731B2Oct 14, 2025

Pyrazolopyrimidine compounds and uses thereof

INCYTE CORP0 citations62
US12083124B2Sep 10, 2024

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP1 citations62
US11111247B2Sep 7, 2021

Pyrazolopyrimidine compounds and uses thereof

INCYTE CORP1 citations62
US11591329B2Feb 28, 2023

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP0 citations52
US9890162B2Feb 13, 2018

Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors

INCYTE CORP0 citations52
US9067921B2Jun 30, 2015

Piperazinylpiperidine derivatives as chemokine receptor antagonists

INCYTE CORP0 citations52
US8039478B2Oct 18, 2011

Purinone derivatives as HM74A agonists

INCYTE CORP1 citations52
US7863285B2Jan 4, 2011

Purinone derivatives as HM74A agonists

INCYTE CORP1 citations52
US8895571B2Nov 25, 2014

Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors

INCYTE CORP0 citations38

XUE CHU-BIAO

3 patents

ZHENG CHANGSHENG

1 patent